Developing a Privacy Conscience: Avoiding a Cambridge Analytica-Type Crisis (Or at Least Be Prepared for One)

The mission of the pharmaceutical industry is straightforward: Educate patients about disease states and the therapies that could effectively treat their conditions, as well as enable them to become active participants in their medical journey. But while the "what” pharmaceutical companies can say and the “how” they must say it is well regulated by the FDA, the privacy challenge comes from the “who” you can educate and how you choose to target them. These very real privacy issues are compounded by an increasingly complex set of federal and state laws, as well as self-regulatory guidelines. Privacy issues are probably unavoidable. But are you prepared? Our CEO Ron Elwell moderated a panel discussion on how you can meet the privacy challenges of today and the future by developing a deeper awareness of your company, your patient and your advertising supply chain.

View the ReplayDownload the Presentation

Lauren Dubick
Director, Group Privacy Policies Counsel

500px-Novartis-Logo.svg-1

 

Ronnie Sharpe
Co-Founder and COO Savvy Cooperative

Savvy-1